GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » Beta

Qianhai Health Holdings (HKSE:00911) Beta : 0.14 (As of Dec. 12, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-12-12), Qianhai Health Holdings's Beta is 0.14.


Qianhai Health Holdings Beta Historical Data

The historical data trend for Qianhai Health Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings Beta Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.88 0.64 0.30 0.32

Qianhai Health Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.30 0.32 0.32 0.44

Competitive Comparison of Qianhai Health Holdings's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's Beta falls into.



Qianhai Health Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Qianhai Health Holdings  (HKSE:00911) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Qianhai Health Holdings Beta Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Chong Siew Hoong 2202 Interest of your spouse
Explorer Rosy Limited
Hou Chung Man 2501 Other
Huang Zhiqun
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Lim Tzea 2101 Beneficial owner
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares

Qianhai Health Holdings Headlines

No Headlines